Darwin

Darwin P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Darwin (7V0.DE) as of Oct 27, 2026 is -5.43. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -4.02 — a change of 35.05% (lower).

P/FCF

-5.43

YoY

35.05%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Darwin is 2025 -5.43 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Darwin was 2024 -4.02 . It decreases by 35.05% lower compared to the previous year.

The Darwin P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2021
12.40 EUR
Jan 1, 2022
1.27 EUR
Jan 1, 2023
-5.77 EUR
Jan 1, 2024
-4.02 EUR
Jan 1, 2025
-5.43 EUR
The Darwin P/FCF history
YEARP/FCFYoY
-5.43+35.05%
-4.02-30.24%
-5.77-553.74%
1.27-89.75%
12.40—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Darwin Stock analysis

What does Darwin do? Darwin AG generates revenue through the development and sale of dietary supplements and cosmetics products. The company leverages biotechnology and AI to create personalized solutions based on scientific lab analysis data. Its fully licensed laboratories offer genetic and metabolomic testing services, including lifestyle personal genomics and embryo screening during IVF to improve success rates. These services are provided to clients seeking personalized health and wellness solutions. The firm's products and services target individuals interested in personalized health, including those undergoing IVF treatments. The company's focus on genetic and metabolomic testing enables it to provide tailored recommendations for dietary supplements and cosmetics. This approach aligns with the growing demand for data-driven health and wellness products in the market. Darwin AG's business model integrates advanced biotechnology with AI to analyze genetic materials, which informs the development of its product lines. The company's fully licensed laboratories ensure compliance and quality in all testing services. Revenue streams are derived from both product sales and service-based offerings, catering to a segment of consumers prioritizing personalized health solutions. Darwin is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Darwin stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Darwin is -5.43 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Darwin changed from -4.02 to -5.43, representing a 35.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Darwin since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Darwin with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Darwin

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Darwin